World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
160
Citations
145522
World Ranking
762
National Ranking
33

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Stefan Zeuzem is affiliated with Goethe University Frankfurt in Germany and has contributed extensively to the field of medicine, particularly focusing on liver diseases and hepatology. Their research portfolio includes close to 600 publications, with substantial work in epidemiology, hepatology, surgery, pulmonary and respiratory medicine, and oncology as subfields of study.

The primary topics covered in Zeuzem's research include:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Gallbladder and Bile Duct Disorders
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Organ Transplantation Techniques and Outcomes

Zeuzem has repeatedly published in several medical journals relevant to their fields of interest. Frequent publication venues include:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • Liver International
  • Journal of Clinical Medicine
  • PLoS ONE

Key recent papers by Zeuzem include:

  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology (2020, Journal of Hepatology)
  • Impact of COVID-19 on global HCV elimination efforts (2020, Journal of Hepatology)
  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis (2020, Journal of Hepatology)
  • Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade (2023, Gut)
  • Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis (2020, Gastroenterology)

Zeuzem has collaborated frequently with several other researchers, including:

  • Jonel Trebicka
  • Markus Cornberg
  • Heiner Wedemeyer
  • Thomas Berg
  • Christoph Sarrazin

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

    Hadziyannis Sj;Sette H;Morgan Tr;Balan

  • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

    Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau

  • Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie

  • Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis

    Richard Moreau;Rajiv Jalan;Pere Gines;Marco Pavesi

  • Treatment of HCV Infection by Targeting MicroRNA

    Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem

  • Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

    Bruce R. Bacon;Stuart C. Gordon;Eric Lawitz;Patrick Marcellin

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Telaprevir for retreatment of HCV infection.

    Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

    Mireen Friedrich-Rust;Mei-Fang Ong;Swantje Martens;Christoph Sarrazin

  • EASL Clinical Practice Guidelines: Management of hepatitis C virus infection European Association for the Study of the Liver ⇑

    Markus Peck;Antonio Craxi;Michael Fried;Stefan Zeuzem

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

    Harry L A Janssen;Monika van Zonneveld;Hakan Senturk;Stefan Zeuzem

  • Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

    Christophe Hézode;Nicole Forestier;Geoffrey Dusheiko;Peter Ferenci

  • Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Jordan J. Feld;Ira M. Jacobson;Christophe Hézode;Tarik Asselah

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

    Fred Poordad;Christophe Hezode;Roger Trinh;Kris V. Kowdley

  • Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

    Thierry Poynard;Patrick Marcellin;Samuel S. Lee;Christian Niederau

Frequent Co-Authors

Christoph Sarrazin
Christoph Sarrazin Goethe University Frankfurt
Eva Herrmann
Eva Herrmann Goethe University Frankfurt
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School
Michael P. Manns
Michael P. Manns Hannover Medical School
Ira M. Jacobson
Ira M. Jacobson New York University
Graham R. Foster
Graham R. Foster Queen Mary University of London
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Wolf O. Bechstein
Wolf O. Bechstein Goethe University Frankfurt
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to diverse online healthcare degrees and flexible career options. For those considering the management side of healthcare, top online mha programs that are cahme accredited offer a way to advance into hospital administration or public health leadership roles, all while studying remotely.

Registered nurses seeking to earn a bachelor's degree may benefit from the accessible rn to bsn with no clinicals programs, which enable professional growth without requiring additional in-person clinical hours. These programs are designed for busy nurses seeking career advancement and increased earning potential.

For those aiming for the highest nursing credentials, it’s important to note the growing popularity of online doctorate options. The fastest online dnp programs can help nurses reach leadership or specialty positions quickly, while dnp programs without dissertation make it easier to earn a terminal degree without intensive research projects.

Online pathways make it possible to balance education with professional and personal commitments, helping students advance in healthcare careers no matter where they are.

Best Scientists Citing Stefan Zeuzem

Trending Scientists